Skip to content
20-F

Annual Report (Foreign)

SOPHiA GENETICS SA SOPH

0001840706-25-000009

← back to feed
Filed
Mar 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Dec 31, 2024 66.69M sh
Current Liabilities FY 2024 · Dec 31, 2023 $35.62M
Total Liabilities FY 2024 · Dec 31, 2023 $54.71M
Current Assets FY 2024 · Dec 31, 2023 $148.05M
Total Assets FY 2024 · Dec 31, 2023 $206.16M
Shares Diluted FY 2024 · Dec 31, 2022 64.1M sh
Operating Cash Flow FY 2024 · Dec 31, 2022 −$70.09M
Eps Diluted FY 2024 · Dec 31, 2022 −$1.36
Eps Basic FY 2024 · Dec 31, 2022 −$1.36
Rd Expense FY 2024 · Dec 31, 2022 $35.37M
Net Income FY 2024 · Dec 31, 2022 −$87.45M
Operating Income FY 2024 · Dec 31, 2022 −$87.82M
Gross Profit FY 2024 · Dec 31, 2022 $31.25M
Cost Of Revenue FY 2024 · Dec 31, 2022 $16.31M
Cash And Equivalents FY 2024 · Dec 31, 2021 $192.96M
Stockholders Equity FY 2024 · Dec 31, 2021 $275.4M